miR-100 alleviates the inflammatory damage and apoptosis of H 2 O 2 -induced human umbilical vein endothelial cells via inactivation of Notch signaling by targeting MMP9
Restricted accessResearch articleFirst published online February, 2022
miR-100 alleviates the inflammatory damage and apoptosis of H 2 O 2 -induced human umbilical vein endothelial cells via inactivation of Notch signaling by targeting MMP9
Thromboangiitis obliterans is a nonatherosclerotic segmental inflammatory disease, and miR-100 plays an anti-inflammatory role in chronic inflammation. Therefore, we hypothesized that miR-100 might alleviate the inflammatory damage and apoptosis of H2O2-induced ECV304 cells and aimed to investigate the relationship between miR-100 and thromboangiitis obliterans and the related molecular mechanism.
Methods
Cell counting kit-8 was used to detect cell viability, and the expression of inflammatory factors and oxidative stress was measured by ELISA. TUNEL assay was used to detect the apoptosis of human umbilical vein endothelial cells after induction by H2O2. Furthermore, the interaction between miR-100 and matrix metalloproteinase-9 was verified by dual-luciferase assay. Quantitative reverse transcription polymerase chain reaction and western blot were used to detect the expression of the adhesion factors, apoptosis-related proteins and Notch pathway-related protein.
Results
The results revealed that miR-100 was decreased in H2O2-induced human umbilical vein endothelial cells. Overexpression of miR-100 attenuated inflammatory response and cell apoptosis in H2O2-induced human umbilical vein endothelial cells. The overexpression of miR-100 inhibited matrix metalloproteinase-9 expression in H2O2-induced human umbilical vein endothelial cells. miR-100 inhibited H2O2-induced human umbilical vein endothelial cell inflammation, oxidative stress, and cell apoptosis via inactivation of Notch signaling by targeting matrix metalloproteinase.
Conclusions
Our study demonstrated that miR-100 reduced the inflammatory damage and apoptosis of H2O2-induced human umbilical vein endothelial cells via inactivation of Notch signaling by targeting matrix metalloproteinase. These findings suggested that miR-100 might be a novel therapeutic target for the prevention of thromboangiitis obliterans.
QajaEFortuneMA.Buerger disease (thromboangiitis obliterans). Treasure Island, FL: StatPearls Publishing, 2019.
2.
LiMDWangYFYangMW, et al. Risk factors, mechanisms and treatments of Thromboangiitis Obliterans: an overview of recent research. Curr Med Chem2019. DOI: 10.2174/0929867326666190816233042.
3.
Shapouri-MoghaddamASaeed ModagheghMHRahimiHR, et al. Molecular mechanisms regulating immune responses in thromboangiitis obliterans: a comprehensive review. Iran J Basic Med Sci2019; 22: 215–224.
4.
YongJZhangSGaoY, et al. Effects of aspirin combined with cilostazol on thromboangiitis obliterans in diabetic patients. Exp Ther Med2018; 16: 5041–5046.
5.
HemsinliDAltunGKaplanST, et al. Hyperbaric oxygen treatment in thromboangiitis obliterans: a retrospective clinical audit. Diving Hyperb Med2018; 48: 31–35.
6.
MensaMDobbsTJessopZM, et al. Homozygous factor V leiden thrombophilia in a patient with histologically confirmed thromboangiitis obliterans. Clin Med Insights Case Rep2019; 12: 1179547619828719.
7.
FiratAIgusB.Endovascular recanalization of thromboangiitis obliterans (Buerger’s disease) in twenty-eight consecutive patients and combined antegrade-retrograde intervention in eight patients. Cardiovasc Intervent Radiol2019; 42: 820–828.
HayesJPeruzziPPLawlerS.MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med2014; 20: 460–469.
10.
DingWDingSLiJ, et al. Aberrant expression of miR-100 in plasma of patients with osteoporosis and its potential diagnostic value. Clin Lab2019; 65.
11.
AkbasFCoskunpinarEAynaciE, et al. Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease. Exp Lung Res2012; 38: 286–294.
12.
VenugopalPKoshyTLavuV, et al. Differential expression of microRNAs let-7a, miR-125b, miR-100, and miR-21 and interaction with NF-kB pathway genes in periodontitis pathogenesis. J Cell Physiol2018; 233: 5877–5884.
13.
OjhaRNandaniRPandeyRK, et al. Emerging role of circulating microRNA in the diagnosis of human infectious diseases. J Cell Physiol2019; 234: 1030–1043.
14.
GonYShimizuTMizumuraK, et al. Molecular techniques for respiratory diseases: microRNA and extracellular vesicles. Respirology2019. DOI: 10.1111/resp.13756.
15.
PankratzFHohnloserCBemtgenX, et al. MicroRNA-100 suppresses chronic vascular inflammation by stimulation of endothelial autophagy. Circ Res2018; 122: 417–432.
16.
De PaolaEVerdileVParonettoMP.Dysregulation of microRNA metabolism in motor neuron diseases: novel biomarkers and potential therapeutics. Noncoding RNA Res2019; 4: 15–22.
17.
LiuLZhangLZhaoS, et al. Non-canonical Notch signaling regulates actin remodeling in cell migration by activating PI3K/AKT/Cdc42 pathway. Front Pharmacol2019; 10: 370.
PhngLKGerhardtH.Angiogenesis: a team effort coordinated by notch. Dev Cell2009; 16: 196–208.
20.
AlabiROFarberGBlobelCP.Intriguing roles for endothelial ADAM10/notch signaling in the development of organ-specific vascular beds. Physiol Rev2018; 98: 2025–2061.
21.
TamaiHKobayashiMTakeshitaK, et al. Possible involvement of Notch signaling in the pathogenesis of Buerger’s disease. Surg Today2014; 44: 307–313.
22.
YangGGongYWangQ, et al. The role of miR-100-mediated Notch pathway in apoptosis of gastric tumor cells. Cell Signal2015; 27: 1087–1101.
23.
SolimanMMowafyKElsaadanyNA, et al. Thromboangiitis obliterans: aggressive angioplasty provides a potential solution (randomized pilot study). SAGE Open Med2020; 8: 2050312120927636.
24.
MokotediLMillenAMEMoganeC, et al. Associations of inflammatory markers and vascular cell adhesion molecule-1 with endothelial dysfunction in collagen-induced arthritis. Eur J Pharmacol2019; 865: 172786.
25.
OtakaY.A histopathological study of the relationship between chronic inflammatory foci and granulation tissues to minute vascular system. Acta Pathol Jpn1963; 13: 215–218.
26.
YamakuchiM.MicroRNAs in vascular biology. Int J Vasc Med2012; 2012: 794898.
27.
KimJ.MicroRNAs as critical regulators of the endothelial to mesenchymal transition in vascular biology. BMB Rep2018; 51: 65–72.
28.
LuoPJiangCJiP, et al. Exosomes of stem cells from human exfoliated deciduous teeth as an anti-inflammatory agent in temporomandibular joint chondrocytes via miR-100-5p/mTOR. Stem Cell Res Ther2019; 10: 216.
29.
WangWLiuYGuoJ, et al. miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a/IL-1ra pathway in mouse breast cancer. Oncogenesis2018; 7: 97.
30.
NgWLYanDZhangX, et al. Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J. DNA Repair2010; 9: 1170–1175.
31.
WangMRenDGuoW, et al. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2. Int J Oncol2014; 45: 362–372.
32.
GrundmannSHansFPKinniryS, et al. MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. Circulation2011; 123: 999–1009.
33.
PaleiACSandrimVCCavalliRC, et al. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. Clin Biochem2008; 41: 875–880.
34.
MartinezMLLopesLFCoelhoEB, et al. Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension. J Cardiovasc Pharmacol2006; 47: 117–122.
35.
FortunaGMFigueiredo-LopesLDias-JuniorCA, et al. A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism. Int J Cardiol2007; 114: 22–27.
36.
ZouridakisEAvanzasPArroyo-EspligueroR, et al. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation2004; 110: 1747–1753.
37.
MakitaSNakamuraMMurakamiH, et al. Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger’s disease). Circulation1996; 94: II211–215.
38.
Van den SteenPEDuboisBNelissenI, et al. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol2002; 37: 375–536.
39.
GalisZSSukhovaGKLarkMW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest1994; 94: 2493–2503.
40.
NewbyAC.Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev2005; 85: 1–31.
41.
ThomasCVCokerMLZellnerJL, et al. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation1998; 97: 1708–1715.
42.
CleutjensJPKandalaJCGuardaE, et al. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol1995; 27: 1281–1292.
43.
Dellalibera-JovilianoRJacob-FerreiraALJovilianoEE, et al. Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans. Vasc Med2012; 17: 73–78.
44.
Bin HafeezBAdhamiVMAsimM, et al. Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res2009; 15: 452–459.
45.
JiaoSLiuYYaoY, et al. miR-124 promotes proliferation and differentiation of neuronal stem cells through inactivating Notch pathway. Cell Biosci2017; 7: 68.
46.
ZhaoYQiaoXWangL, et al. Correction to: Matrix metalloproteinase 9 induces endothelial-mesenchymal transition via Notch activation in human kidney glomerular endothelial cells. BMC Mol Cell Biol2020; 21: 72.
47.
FunahashiYShawberCJSharmaA, et al. Notch modulates VEGF action in endothelial cells by inducing matrix metalloprotease activity. Vasc Cell2011; 3: 2.
48.
HuCDongZL.MicroRNA-212 promotes the recovery function and vascular regeneration of endothelial progenitor cells in mice with ischemic stroke through inactivation of the notch signaling pathway via downregulating MMP9 expression. J Cell Physiol2019; 234: 7090–7103.
